Role of intracellular calcium in acute thermal pain perception

Neuropharmacology

Volumn 47, Issue 6, 2004, Pages 935-944

  Galeotti, Nicoletta ^a   Bartolini, Alessandro ^a   Ghelardini, Carla ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Analgesia; Hyperalgesia; Inositol 1,4,5 trisphosphate; InsP3 receptor; Intracellular Ca++; Ry receptor

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; CALCIUM; CHLOROCRESOL; DEXTRO INOSITOL; HEPARIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL DERIVATIVE; LEVO INOSITOL; RYANODINE; RYANODINE RECEPTOR; THAPSIGARGIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; HOT PLATE TEST; HYPERALGESIA; MALE; MOUSE; NEUROMODULATION; NONHUMAN; OBSERVATION; PAIN THRESHOLD; PRIORITY JOURNAL; SPINAL CORD;

ACUTE DISEASE; ANIMALS; BEHAVIOR, ANIMAL; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM-TRANSPORTING ATPASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GALLIC ACID; HEAT; HYPERALGESIA; INJECTIONS, INTRAVENTRICULAR; INOSITOL 1,4,5-TRISPHOSPHATE; MALE; MICE; MUSCULOSKELETAL EQUILIBRIUM; PAIN; PAIN THRESHOLD; REACTION TIME; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; THAPSIGARGIN;

EID: 7444244998     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.07.001     Document Type: Article

References (32)

1. 2+-ATPase inhibitor thapsigargin on spinal nociception in rats. Pharmacology. 62:(3):1995;145-150
2. Bernstein M.A., Welch S.P. Alteration in L-type calcium channels in the brain and spinal cord of acutely treated and morphine-tolerant mice. Brain Research. 696:1995;83-88
3. Berridge M.J. Neuronal calcium signaling. Neuron. 21:1998;13-26
4. Bowersox S.S., Gadbois T., Singh T., Pettus M., Wang Y.-X., Luther R.R. Selective N-type neuronal voltage-sensitive calcium channel blockers, SNX-111, produces spinal antinociception in rat model of acute, persistent and neuropathic pain. Journal of Pharmacology and Experimental Therapeutics. 279:1996;1243-1249
5. Coderre T.J., Melzack R. The role of NMDA receptor-operated calcium channels in persistent nociception after formalin-induced tissue injury. Journal of Neuroscience. 12:1992;3671-3675
6. Damaj M.I., Welch S.P., Martin B.R. Involvement of calcium and L-type channels in nicotine-induced antinociception. Journal of Pharmacology and Experimental Therapeutics. 266:1993;1330-1338
7. Fill M., Copello J.A. Ryanodine receptor calcium release channels. Physiological Reviews. 82:2002;893-922
8. 2+]. Journal of Physiology. 450:1992;217-246
9. 3 pathway is involved in muscarinic antinociception. Neuropsychopharmacology. 28:2003;888-897
10. Ghelardini C., Galeotti N., Bartolini A. Caffeine induces central cholinergic analgesia. Naunyn-Schmiedebergs Archives of Pharmacology. 356:1997;590-595
11. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. British Journal of Pharmacology and Chemotherapy. 12:1957;12-15
12. Harris R.A., Loh H.H., Way E.L. Effects of divalent cations, cation chelators and an ionophore on morphine analgesia and tolerance. Journal of Pharmacology and Experimental Therapeutics. 195:1975;488-498
13. 2+ release channel activity by phosphorylation of the skeletal muscle ryanodine receptor. FEBS Letters. 332:1993;237-242
14. Jonas S., Sugimori M., Llinas R. Is low molecular weight heparin a neuroprotectant? Annals of the New York Academy of Science. 825:1997;389-393
15. Kamei J., Taki K., Ohsawa M., Hitosugi H. Modulation of the formalin-induced nociceptive response by diabetes: possible involvement of intracellular calcium. Brain Research. 862:2000;257-261
16. Kunapuli P., Onorato J.J., Hosey M.M., Benovic J.L. Expression, purification, and characterization of the G protein-coupled receptor kinase GRK5. Journal of Biological Chemistry. 269:1994;1099-1105
17. 2+ antagonist, 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8): studies in smooth muscles. European Journal of Pharmacology. 27:1974;25-33
18. McPherson P.S., Kim Y.K., Valdivia H., Knudson C.M., Takekura H., Franzini-Armstrong C., Coronado R., Campbell K.P. The brain ryanodine receptor: a caffeine-sensitive calcium release channel. Neuron. 7:1991;17-25
19. 2+ signaling. Current Opinion in Neurobiology. 7:1997;339-345
20. Narita M., Ohsawa M., Mizoguchi H., Aoki T., Suzuki T., Tseng L.F. Role of the phosphatidylinositol-specific phospholipase C pathway in delta-opioid receptor-mediated antinociception in the mouse spinal cord. Neuroscience. 99:2000;327-331
21. O'Callaghan J.P., Holtzman S.G. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure. Journal of Pharmacology and Experimental Therapeutics. 192:1975;497-505
22. Ohsawa M., Kamei J. Role of intracellular calcium in thermal allodynia and hyperalgesia in diabetic mice. Brain Research. 833:1999;278-281
23. Ohsawa M., Nagase H., Kamei J. Role of intracellular calcium in modification of mu and delta opioid receptor-mediated antinociception by diabetes in mice. Journal of Pharmacology and Experimental Therapeutics. 286:1998;780-787
24. Person D.L., Kissin I., Brown P.T., Xavier A.V., Vinik H.R., Bradley E.L. Morphine-caffeine analgesic interaction in rats. Anesthesia and Analgesia. 64:1985;851-856
25. Prado W.A. Involvement of calcium in pain and antinociception. Brazilian Journal of Medical and Biological Research. 34:2001;449-461
26. Sawynok J., Reid A.R., Doak G.J. Caffeine antinociception in the rat hot-plate and formaline tests and locomotor stimulation: involvement of noradrenergic mechanisms. Pain. 61:1995;203-207
27. Smith F.L., Dewey W.L. Evidence that endogenous opioids mediate the antinociceptive effects of intrathecally administered calcium in mice. Pain. 85:1992;9-18
28. Smith F.L., Stevens D.L. Calcium modulation of morphine analgesia: role of calcium channels and intracellular pool calcium. Journal of Pharmacology and Experimental Therapeutics. 272:1995;290-299
29. Treiman M., Caspersen C., Christensen S.B. A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca(2+)-ATPases. Trends in Pharmacological Sciences. 19:1998;131-135
30. Vaught J., Pelley K., Costa L.G., Sether P., Enna S.J. A comparison of the antinociceptive responses to GABA-receptor agonists THIP and baclofen. Neuropharmacology. 24:1985;211-216
31. Vocci F.J. Jr., Welch S.P., Dewey W.L. Differential effects of divalent cations, cation chelators and an ionophore (A23187) on morphine and dibutyryl guanosine 3′: 5′-cyclic monophosphate antinociception. Journal of Pharmacology and Experimental Therapeutics. 214:1980;463-466
32. Welch S.P., Dewey W.L. A characterization of the antinociception produced by intracerebroventricular injection of 8-(N,N-diethylamino)octyl-3,4,5- trimethoxybenzoate in mice. Journal of Pharmacology and Experimental Therapeutics. 239:1986;320-326